Status:
UNKNOWN
Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)
Lead Sponsor:
The University of Hong Kong
Conditions:
Stroke, Cardiovascular
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stroke remains the leading cause of mortality and morbidity worldwide. Patients surviving the first ever stroke remain at high risk of stroke recurrence. While the cause of stroke recurrence is multif...
Detailed Description
The trial will primarily be conducted in Hong Kong SAR, Macau SAR, and mainland China. It is a prospective, multi-centered, randomized controlled, parallel-group study to compare the time to detect AF...
Eligibility Criteria
Inclusion
- age \>= 18 years
- history of ischemic stroke within 5 years
- voluntarily agrees to participate by providing written informed consent
Exclusion
- previously documented AF and/or atrial flutter
- long-term anticoagulation therapy
- short life expectance (\< 1year) due to concomitant medical condition(s)
- cardiac implantable electronic device
- inability or refusal to provide inform consent
- lack of skills in operating simple electronic devices
- unavailability of a mobile network service in the place of residence
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1740 Patients enrolled
Trial Details
Trial ID
NCT04523649
Start Date
June 1 2022
End Date
December 31 2025
Last Update
March 15 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.